You can cut trial costs significantly by designing a hybrid or decentralized clinical trial (DCT) with remote microsampling and tele-technologies so your study volunteers can participate from home…and stay engaged until a trial’s completion. How can you justify introducing disruptive technology into a trial design? A DCT with remote microsampling lowers costs and is a great strategy to increase the size and diversity of your study population across wider areas. This helps you meet the requirement for diversity in clinical trials, as stipulated by a new law.
View & Download Our Infographic on Microsampling in Decentralized Trials
